{
    "2019-09-17": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Novartis Announces New Data on Spondylitis Drug Cosentyx",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Spondylitis",
                        "Drug",
                        "Cosentyx",
                        "New Data"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "J&J Files sBLA for Tremfya With FDA for Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "J&J",
                        "Tremfya",
                        "FDA",
                        "Psoriatic Arthritis",
                        "sBLA"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Alder (ALDR) Stock Up on Acquisition Agreement With Lundbeck",
                "features": {
                    "keywords": [
                        "Alder",
                        "Stock Up",
                        "Acquisition",
                        "Lundbeck"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Is Novartis (NVS) a Great Value Stock Right Now?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Value Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study",
                "features": {
                    "keywords": [
                        "Acceleron",
                        "Muscular Dystrophy",
                        "Drug Trial",
                        "Aclaris",
                        "Late-Stage Study"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-25",
                "original_text": "Alcon Finance Corporation -- Moody's assigns Baa2 ratings to Alcon Finance Corporation's new notes",
                "features": {
                    "keywords": [
                        "Alcon Finance Corporation",
                        "Moody's",
                        "Baa2 ratings",
                        "new notes"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}